MP Diagnostic Tests for Allergic and Immune Deficiency Diseases of Uncertain Efficacy

Similar documents
Topic: Allergy Tests of Uncertain Efficacy Date of Origin: January Section: Laboratory Last Reviewed Date: June 2014

ALLERGY TESTING AND TREATMENT

The intent of this policy is to address only those allergy tests that are considered not medically necessary.

Allergy Testing and Allergy Immunotherapy

MEDICAL POLICY Allergy Testing & Treatments

Medical Coverage Policy Allergy Testing EFFECTIVE DATE: POLICY LAST UPDATED:

Selected Blood, Serum and Cellular Allergy and Toxicity Tests Corporate Medical Policy

Corporate Medical Policy

Clinical Policy: Allergy Testing and Therapy Reference Number: AZ.CP.MP.100 (Adult members 21 years)

ALLERGY TESTING AND TREATMENT

Clinical Policy: Allergy Testing and Therapy

MEDICAL POLICY MEDICAL POLICY DETAILS POLICY STATEMENT. Page: 1 of 9

Clinical Policy Title: Allergy testing

MEDICAL POLICY SUBJECT: ALLERGY TESTING

See Policy CPT CODE section below for any prior authorization requirements

COVERAGE POLICY. This policy is current at the time of publication. Centene Corporation retains the right to change or amend this policy at any time.

Allergy Testing Corporate Medical Policy

Clinical Policy: Allergy Testing and Therapy Reference Number: CP.MP.100 Last Review Date: 01/18

Clinical Policy Title: Allergy testing

Clinical Policy: Allergy Testing and Therapy Reference Number: TX.CP.MP.100

Clinical Policy Title: Allergy testing

ALLERGY TESTING AND ALLERGY IMMUNOTHERAPY

New Test ANNOUNCEMENT

Clinical Policy Title: Allergy testing

Allergy Testing and Non-Pharmacologic Treatment

Cigna Medical Coverage Policy

Clinical Policy: Allergy Testing and Therapy

Antigen Leukocyte Antibody Test

Hypersensitivity Reactions and Peanut Component Testing 4/17/ Mayo Foundation for Medical Education and Research. All rights reserved.

ODACTRA House Dust Mite (Dermatophagoides farina & Dermatophagoides pteronyssinus) allergen extract sublingual tablet

Clinical Policy: Allergy Testing and Therapy Reference Number: AZ.CP.MP.100 (Members < 21 years of age)

Introduction. Methods. Results 12/7/2012. Immunotherapy in the Pediatric Population

Allergy Testing in Childhood: Using Allergen-Specific IgE Tests

Allergic Disorders. Allergic Disorders. IgE-dependent Release of Inflammatory Mediators. TH1/TH2 Paradigm

Allergic Disorders. Allergic Disorders. IgE-dependent Release of Inflammatory Mediators. TH1/TH2 Paradigm

Local Coverage Determination (LCD): RAST Type Tests ( L30524 )

IMMUNOTHERAPY IN ALLERGIC RHINITIS

Antigen Leukocyte Antibody Test

Allergy Skin Prick Testing

Pharmacy Coverage Guidelines are subject to change as new information becomes available.

Learning Objective. Conflicts of Interest 11/28/13

SLIT: Review and Update

Defense & the Immune System. Immune System Agenda 4/28/2010. Overview. The bigger picture Non specific defenses Specific defenses (Immunity)

Anti-allergic Effect of Bee Venom in An Allergic Rhinitis

Ear, Nose & Throat (ENT) - Head & Neck Surgery. Allergic Rhinitis (Sinus)

Persia Pourshahnazari MD, FRCPC Clinical Immunology and Allergy November 3, 2018

Xolair. Xolair (omalizumab) Description

알레르기질환관련 진단적검사의이해 분당서울대병원알레르기내과 김세훈

INVESTIGATIONS & PROCEDURES IN PULMONOLOGY. Immunotherapy in Asthma Dr. Zia Hashim

Xolair. Xolair (omalizumab) Description

Tetsuji WAKUDA, Masanao SHIBASAKI,Tadashi TANITSU* National University Corporation, Tsukuba University of Technology *Cooperation with research

Ailléirge Péidiatraiceach. Pediatric Allergy 3/9/2018. Disclosures & Conflicts Of Interest

Coverage Criteria: Express Scripts, Inc. monograph dated 03/03/2010

Mouse Anti-HDM IgG Antibody Assay Kit

Sensitivity to Sorghum Vulgare (Jowar) Pollens in Allergic Bronchial Asthma and Effect of Allergen Specific Immunotherapy

Overview Of Allergy Testing Methods

What are Allergy shots / SCIT?

Establishment of Two Novel ELISA Methods for Dermatophagoides farinae-specific IgE Detection with Recombinant Group 2 Allergen

Clinical and Molecular Allergy

Mouse Serum Anti-HDM IgE Antibody Assay Kit

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

TO BE RESCINDED 2

Seasonal Allergic Rhinoconjunctivitis

Glossary of Terms ASCIA EDUCATION RESOURCES (AER) PATIENT INFORMATION

Pediatric Allergy Allergy Related Testing

Allergy Testing and Treatment ALLERGY TESTING AND TREATMENT HS-190. Policy Number: HS-190. Original Effective Date: 9/23/2010

IgE-mediated allergy in elderly patients with asthma

Retrospective Study of Specific Immunotherapy What Should Be Done in the Future

Path2220 INTRODUCTION TO HUMAN DISEASE ALLERGY. Dr. Erika Bosio

Allergies & Hypersensitivies

Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document.

By the end of this lecture physicians will:

Skin prick testing: Guidelines for GPs

Antigen Leukocyte Antibody Test. Description

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

4/28/2016. Host Defenses. Unit 8 Microorganisms & The Immune System. Types of Innate Defenses. Defensive Cells Leukocytes

UNDERSTANDING ALLERGY IMMUNOTHERAPY

Corporate Medical Policy Allergy Immunotherapy (Desensitization)

Allergy Glossary of Terms

Food Allergy I. William Reisacher, MD FACS FAAOA Department of Otorhinolaryngology Weill Cornell Medical College

Immunologic Mechanisms of Tissue Damage. (Immuopathology)

Hypersensitivity diseases

Introduction. Allergic Rhinitis. Seventh Pediatric Asthma Education Conference 5/9/2018

your triggers? Information about a simple lab test that lets you Know Your IgE.

Clinical Implications of Asthma Phenotypes. Michael Schatz, MD, MS Department of Allergy

Paediatric Food Allergy. Introduction to the Causes and Management

Human Allergen Specific IgE ELISA Kits

Allergy Testing and Practical Mitigation Measures

Food Allergy , The Patient Education Institute, Inc. imf10101 Last reviewed: 10/15/2017 1

Comparison of VIDAS Stallertest and Pharmacia CAP Assays for Detection of Specific IgE Antibodies in Allergic Children

WILLIAM B. COBB, M.D. KEITH MATHENY, M.D. EWEN TSENG, M.D. KENNY CARTER, M.D.

AEROALLERGEN IMMUNOTHERAPY FOR ALLERGIC RHINITIS

Does rhinitis. lead to asthma? Does sneezing lead to wheezing? What allergic patients should know about the link between allergic rhinitis and asthma

ALLERGENIC EXTRACTS POLLENS, MOLDS EPIDERMALS, INSECTS DUSTS, FOODS AND MISCELLANEOUS INHALANTS

NOTES: CH 43, part 2 Immunity; Immune Disruptions ( )

Contractor Name: Novitas Solutions, Inc. Contractor Number: Contractor Type: MAC B. LCD ID Number: L36241 Status: A-Approved

Precise results for safe decisions. How to better define and manage peanut allergy

Transcription:

Medical Policy MP 2.04.500 Diagnostic Tests for Allergic and Immune Deficiency Diseases of Uncertain Efficacy Last Review: 04/30/2018 Effective Date: 04/30/2018 Section: Medicine Related Policies 9.01.502 Experimental / Investigational Services DISCLAIMER Our medical policies are designed for informational purposes only and are not an authorization, explanation of benefits or a contract. Receipt of benefits is subject to satisfaction of all terms and conditions of the coverage. Medical technology is constantly changing, and we reserve the right to review and update our policies periodically. POLICY The following allergy tests are considered investigational, because they have not been shown to improve net health outcomes: 1. Antigen leukocyte cellular antibody (ALCAT) automated food test 2. Applied kinesiology allergy test 3. Conjunctival challenge test (ophthalmic mucous membrane test) 4. Cytotoxic food tests 5. Electrodermal testing (also known as electro-acupuncture) 6. Hair analysis 7. IgG/IgG4 allergen specific antibody test and food tests 8. Iridology 9. Leukocyte histamine release test (LHRT) 10. Nasal challenge test 11. Passive transfer of P-X (Prausnitz-Küstner) test (now considered obsolete-and replaced by Radioallergosorbent tests) 12. Provocation-neutralization food or food additive allergy test 13. Rebuck skin window test (no longer in use) POLICY GUIDELINES The following allergy tests are considered clinically useful for allergy confirmation by the American Academy of Allergy, Asthma, and Immunology (AAAI) and the American College of Allergy, Asthma and Immunology (ACAAI) in the diagnosis and management of the allergic patient 1 : Bronchial challenge test Double-blind food challenge test Intradermal skin testing Patch test Percutaneous skin tests such as the scratch, prick, or puncture tests

Photo patch test Specific IgE in vitro tests such as Radioallergosorbent Test (RAST), Multiple Radioallergosorbent Tests (MAST), Fluorescent Allergosorbent Test (FAST), Enzyme-linked Immunosorbent Assay (ELISA), and the ImmunoCAP IgE test Total serum IgE concentration This policy addresses only allergy tests which are unproven or inappropriate based upon the scientific literature. BENEFIT APPLICATION BLUE CARD/NATIONAL ACCOUNT ISSUES State or federal mandates (eg, Federal Employee Program) may dictate that certain U.S. Food and Drug Administration approved devices, drugs, or biologics may not be considered investigational, and thus these devices may be assessed only by their medical necessity. BACKGROUND ALLERGY TESTS OF UNCERTAIN EFFICACY This policy addresses only allergy tests of uncertain efficacy and those used primarily in research settings. Tests which may be considered useful in the clinical setting, as noted above, are not addressed in this policy. Antigen Leukocyte Cellular Antibody (ALCAT) Automated Food Test The ALCAT automated food test measures whole blood leukocytes by a proprietary process that identifies allergens which cause an increase in leukocyte activity. An electronic counter measures the change in number and size of white blood cells which have been incubated with purified food or mold extracts. A histogram is produced based on cell count and cell size. Individually processed test samples are compared with a 'Master Control' graph. Scores are generated by relating these effective volumetric changes in white blood cells to the control curve. Applied Kinesiology (Or Muscle Strength Test) Muscle strength in the extremities is measured before and after a person is exposed to an allergen. Strength in the opposing arm is measured as a person holds a container of allergen extract in the opposite hand or ingests an allergen. A decrease in strength indicates the presence of disease and various nutritional supplements may be recommended. Cytotoxic Food Tests This test involves the response of especially collected white blood cells to the presence of food extracts to which the patient is allergic. A technician observes the unstained cells for changes in shape and appearance of the leukocytes. Swelling, vacuolation, crenation, or other cytotoxic changes in cell morphology are taken as evidence of allergy to the food. Electrodermal Testing (Also Known As Electro-Acupuncture) This test measures changes in skin resistance while a person is exposed to an allergen; either food or inhalant using an instrument that measures the electrical resistance of the skin. A drop in the resistance of the skin is believed to indicate the presence of allergy. Hair Analysis Original Policy Date: January 2010 Page: 2

Hair is analyzed for the presence (or lack) of various minerals and toxins. Findings are correlated to nutritional deficiencies or disease. Recommendations for diet and supplements are provided based on the analysis. Iridology According to the AAAI, iridology attempts to relate the anatomical features in the iris to various systemic diseases. Igg/Igg4 Antibody Test And Food Specific Igg/Igg4 Tests There are four subclasses of immunoglobulin G. Selective deficiencies in one or more of the four IgG subclasses are seen in some patients with repeated infections. Measurements of IgG and specifically IgG4 antibodies have been used in research settings as diagnostic and prognostic tests to determine response to allergy treatments. Passive Transfer Of P-X (Prausnitz-Kustner) Test This technique involves prick, scratch, or intradermal transfer of serum from a sensitized individual into a non-allergic volunteer. The volunteer is then challenged with the allergen by skin testing. A wheal or a flare response indicates a positive reaction. This procedure is now considered obsolete and has been replaced by the Radioallergosorbent Test (RAST) test. Provocative-Neutralization Tests For Food (Or Food Additive Allergy Test) This procedure is performed by injecting (intradermal or subcutaneous), or placing under the tongue (sublingual), dilute extracts of the suspected food or inhalant allergen and observing the patient s response or reaction. A symptomatic response indicates an allergy to that food or inhalant, and the reaction can be neutralized by application of a similar extract of a lesser dilution. Rebuck Skin Window Test This is a type of skin testing where the skin surface is stripped or broken to cause serious oozing. This area is then covered by a glass plate, coated with the allergen to be tested, and taped in place for 24 hours. At the end of that time the plate is removed, and the cells under the plate and the surrounding skin are checked for any changes. An eosinophilic exudate typical of an allergic reaction appears in the area of the stripped epidermis. The results are very difficult to interpret and are not practical for general use. The procedure is no longer in use. ALLERGY TESTS IN THE RESEARCH SETTING The following tests are primarily used in the research setting: Conjunctival challenge test With conjunctival testing, an allergenic extract is placed into the conjunctival sac of the eye followed by observation for redness, itchiness, tearing of the eye, and other similar symptoms. According to the AAAI, these tests are often used in research protocols that require an objective standard for evaluating clinical sensitivity to an allergen. Leukocyte Histamine Release Test (LHRT) In this testing, leukocytes from the serum of an allergic individual are observed for histamine release in the presence of an antigen. The commercial availability of simplified and automated methods of laboratoryanalysis has renewed interest in the clinical applications of LHRT in the evaluation of food, inhalant, and drug allergies. The AAAI guidelines for this test indicate it is primarily used in a research setting. Original Policy Date: January 2010 Page: 3

Nasal challenge test This test provides precise measurements of changes in nasal airway resistance along with observations such as number of sneezes and measurement of inflammatory mediators in the nasal secretions after exposure to an allergen. The more commonly known "sniff test," uses a visual assessment of mucosal swelling and rhinorrhea after a small amount of dry pollen is inhaled. RATIONALE EFFECTIVENESS The following tests have no randomized, controlled clinical trials documenting outcomes and impact on 1-3, 11-14 treatment decisions and/or results from clinical trials are inconclusive or contradictory: REFERENCES Antigen leukocyte cellular antibody (ALCAT) test Applied kinesiology Cytotoxic tests Electrodermal testing Hair analysis IgG and IgG4 allergen specific antibody or food test Iridology Passive transfer or P-X test Provocation-neutralization Rebuck skin window test 1. Wuthrich B, Unproven techniques in allergy diagnosis, J Investig Allergol Clinic Immunol 2005;15:86-90 cited in American Academy of Allergy and Immunology Program Directors Core Curriculum Outline 2008 2. Bernstein IL, Li JT, Bernstein DI et al. Allergy Diagnostic Testing: An Updated PracticeParameter Ann Allergy Asthma Immunol 2008;100:S1-148 3. Griese M, Kusenbach G, Reinhardt D. Histamine release test in comparison to standard tests in diagnosis of childhood allergic asthma. Ann Allergy 1990;65(1):46-51 4. Skov PS, Mosbech M, Norn S et al. Sensitive glass microfibre-based histamine analysis for allergy testing in washed blood cells. Results compared with conventional leukocyte histamine release assay. Allergy 1985;40(3):213-8 5. Ostergaard PA, Ebbensen F, Nolte H et al. Basophil histamine release in the diagnosis of house dust mite and dander allergy of asthmatic children. Comparison between prick test, RAST, basophil histamine release and bronchial provocation. Allergy 1990;45(3):231-5 6. Kleine-Tebbe J, Werfel S, Roedsgaard D et al. Comparison of fiberglass-based histamine assay with a conventional automated fluorometric histamine assay, case history, skin prick test, and specific serum IgE in patients with milk and egg allergic reactions. Allergy 1993;48(1):49-53 7. Kleine-Tebbe J, Galleani M, Jeep S et al. Basophil histamine release in patients with birch pollen hypersensitivity with and without allergic symptoms to fruits. Allergy 1992;47(6):618-23 8. Paris-Kohler A, Demoly P, Persi L et al. In vitro diagnosis of cypress pollen allergy by using cytofluorometric analysis of basophils (Bastotest). J Allergy Clin Immunol 2000;105(2 pt 1):339-45 9. Nolte H, Storm K, Schiotz PO. Diagnostic value of a glass fibre-based histamine analysis for allergy testing in children. Allergy 1990;45(3):213-23 Original Policy Date: January 2010 Page: 4

10. Noh G, Ahn H-S, Cho N-Y et al. The clinical significance of food specific IgE/IgG4 in food specific atopic dermatitis. Pediatr Allergy Immunol 2007;18:63-70 11. Aberer W, Hawranek T, Reider N et al. Immunoglobulin E and G antibody profiles to grass pollen allergens during a short course of sublingual immunotherapy. J Investig Allergol Clin Immunol 2007;17(3):131-6 12. Huang S-W. Follow-up of children with rhinitis and cough associated with milk allergy. Pediatr Allergy Immunol 2007;18:81-5 13. Chapman JA, Bernstein IL, Lee RE et al. Food allergy: a practice parameter. Annals of Allergy, Asthma, & Immunol 2006;96:S1-268 14. Miadonna A, Leggieri E, Tedeschi A, et al. Clinical significance ofspecific IgE determination on nasal secretion. Clin Allergy 1983;13(2):155 164 CODES Codes Number Description CPT 82784 Gammaglobulin (immunoglobulin); IgA, IgD, IgG, IgM, each 83516 Immunoassay for analyte other than infectious agent antibody or infectious agent antigen; qualitative or semiquantitative, multiple step method 86001 Allergen specific IgG quantitative or semiquantitative; each allergen 86003 Allergen specific IgE; quantitative or semiquantitative, each allergen 86005 Allergen specific IgE; qualitative, multiallergen screen (dipstick, paddle, or disk) 86343 Leukocyte Histamine Release Test (LHRT) 86486 Skin test; unlisted antigen, each 86807 Serum screening for cytotoxic percent reactive antibody (PRA); standard method 86808 Serum screening for cytotoxic percent reactive antibody (PRA); quick method 95060 Ophthalmic mucous membrane tests 95065 Direct nasal mucous membrane test 95076 Ingestion challenge test (sequential and incremental ingestion of test items, eg, food, drug or other substance); initial 120 minutes of testing 95079 Ingestion challenge test (sequential and incremental ingestion of test items, eg, food, drug or other substance); each additional 60 minutes of testing (List separately in addition to code for primary procedure) 95199 Unlisted allergy/clinical immunologic service or procedure 96902 Microscopic examination of hairs plucked or clipped by the examiner (excluding collection by patient) to determine telogen and anagen counts, Original Policy Date: January 2010 Page: 5

or structural hair shaft abnormality 97813 Acupuncture, 1 or more needles; with electrical stimulation, initial 15 minutes of personal one-onone contact with the patient 97814 Acupuncture, 1 or more needles; with electrical stimulation, each additional 15 minutes of personal one-on-one contact with the patient, with re-insertion of needle(s) (List separately in addition to code for primary procedure) 99199 Unlisted special service, procedure or report HCPCS P2031 Hair analysis (excluding arsenic) POLICY HISTORY Date Action Reason 03/19/14 Replace policy- update Policy renumbered from 2.04.97 to 2.04.300. only 04/07/16 Replace policy Blue Cross of Idaho annual review; no change to policy statement. 04/25/17 Replace policy Blue Cross of Idaho annual review; no change to policy statement. 04/30/18 Replace policy Blue Cross of Idaho annual review; no change to policy statement. Medical policy renumbered from 2.04.300 to 2.04.500. Added codes: P2031, 82784, 95060, 95065, 95199, 97813, 97814 and 99199. Title changed from Unproven and Inappropriate Diagnostic Tests for Allergic and Immune Deficiency Diseases to Diagnostic Tests for Allergic and Immune Deficiency Diseases of Uncertain Efficacy. Original Policy Date: January 2010 Page: 6